U.S. Senate negotiators near agreement on $10 bln round of COVID funds

Author of the article: WASHINGTON — U.S. Senate negotiators on Thursday were nearing a deal on a $10 billion COVID-19 bill to help the federal government acquire more vaccines and medical supplies as it prepares for future variants of the virus that upended American life. Senate Majority Leader Chuck Schumer, a Democrat, said senators were…
U.S. Senate negotiators near agreement on $10 bln round of COVID funds

Author of the article:

WASHINGTON — U.S. Senate negotiators on Thursday were nearing a deal on a $10 billion COVID-19 bill to help the federal government acquire more vaccines and medical supplies as it prepares for future variants of the virus that upended American life.

Senate Majority Leader Chuck Schumer, a Democrat, said senators were “close to a final agreement” on a bill aiming to shore up stockpiles to be used both domestically and internationally.

If a deal is finalized in coming days, the Senate might be able to pass the bill and send it to the House of Representatives before the start of a spring recess at the end of next week.

“We need more money right away so we have enough vaccines and testing and life-saving therapeutics,” Schumer said in a speech to the Senate.

The amount is a tiny fraction of the $4.6 trillion Congress has approved since early 2020 to fight the virus, much of which was devoted to offsetting its heavy economic hit.

Early this month, Congress failed to pass a $15.6 billion relief bill amid Republican opposition to new federal spending. Many Democrats, meanwhile, rebelled against taking back some money earmarked to help state and local governments in order to pay for the new round of coronavirus relief.

Schumer said a failure to adequately prepare for a possible new coronavirus variant could reverse progress in fighting the pandemic and reopening most American institutions.

Republican Senator Roy Blunt told reporters that nearly half of the financing for the bill would come from recapturing funding from previous COVID aid laws that were intended to help performing arts venues recover from being shuttered during long periods of the pandemic and for aid to aviation manufacturers.

COVID-19 has caused 6.5 million deaths globally, with 980,000 in the United States alone. While the pandemic has been showing signs of easing, prompting many to shed the medical masks that had become part of daily life, U.S. deaths still lead the world with an average of 710 per day. (Reporting by Richard Cowan; Editing by Scott Malone and David Gregorio)

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Dynamic Technologies Group reports 2021 Results
Read More

Dynamic Technologies Group reports 2021 Results

Author of the article: The Company continues to execute its four-pronged plan: advance co-ventures for recurring revenue, scale the ride business to reflect demand, focus our technology development on product innovation and revenue diversification and aggressively expand our parts and service business. TORONTO, April 29, 2022 (GLOBE NEWSWIRE) — Dynamic Technologies Group Inc. (TSXV: DTG,…
Graphenea launches specialty chemical spin-off KIVORO
Read More

Graphenea launches specialty chemical spin-off KIVORO

Author of the article: Published Dec 15, 2022  •  Last updated 19 hours ago  •  2 minute read Join the conversation Analysis of a specialty chemical GNW SAN SEBASTIAN, Spain, Dec. 15, 2022 (GLOBE NEWSWIRE) — Graphenea S.A., a world-leading graphene producer, has launched a spin-off company. KIVORO is a specialty chemicals company that is focused…
ECB’s time to hike, Italy’s time for more instability
Read More

ECB’s time to hike, Italy’s time for more instability

Author of the article: (Updates to include Draghi’s resignation) A look at the day ahead in markets from Tommy Wilkes. If the European Central Bank’s inflation headache wasn’t bad enough, its first interest rate rise since 2011 will land on the day the government of its third-largest member state, Italy, fell apart. . Mario Draghi…